Larvol Delta - ResQ108BPANC-OpenLabel-Phase-1-Clinical-Trial-of-Neoadjuvant-Nogapendekin-Alfa-Inbakicept-Sotevtamab-and-Zabadinostat-in-Combination-With-Gemcitabine-and-NabPaclitaxel-for-Participants-With-Borderline-Resectable-or-Locally-Advanced-Pancreatic-Cancer

albumin-bound paclitaxel - Generic mfg.

zabinostat (CXD101) - IngenOx Therap

sotevtamab (AB-16B5) - Alethia BioTherap

gemcitabine - Generic mfg.

Anktiva (nogapendekin alfa inbakicept-pmln) - ImmunityBio

http://clinicaltrials.gov/ct2/show/NCT07488884

Apr 30, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next